NDC 72356-103

ZILXI

Minocycline

ZILXI is a Topical Aerosol, Foam in the Human Prescription Drug category. It is labeled and distributed by Foamix Pharmaceuticals Inc.. The primary component is Minocycline Hydrochloride.

Product ID72356-103_116f9ade-1bdc-4162-98d8-d3a0c592f419
NDC72356-103
Product TypeHuman Prescription Drug
Proprietary NameZILXI
Generic NameMinocycline
Dosage FormAerosol, Foam
Route of AdministrationTOPICAL
Marketing Start Date2020-10-01
Marketing CategoryNDA / NDA
Application NumberNDA213690
Labeler NameFoamix Pharmaceuticals Inc.
Substance NameMINOCYCLINE HYDROCHLORIDE
Active Ingredient Strength15 mg/g
Pharm ClassesTetracycline-class Drug [EPC],Tetracyclines [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 72356-103-03

1 CAN in 1 CARTON (72356-103-03) > 30 g in 1 CAN
Marketing Start Date2020-10-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ZILXI" or generic name "Minocycline"

NDCBrand NameGeneric Name
69489-212ZILXIMinocycline
72356-103ZILXIMinocycline
69489-201AMZEEQMinocycline
72356-101AMZEEQMinocycline
42291-589MinocyclineMinocycline
42291-591MinocyclineMinocycline
49884-511MinocyclineMinocycline
49884-512MinocyclineMinocycline
49884-513MinocyclineMinocycline
63629-2228MinocyclineMinocycline
63629-2229MinocyclineMinocycline

Trademark Results [ZILXI]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ZILXI
ZILXI
88758482 not registered Live/Pending
Foamix Pharmaceuticals Ltd
2020-01-14
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.